INR 268.45
(0.41%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -164.47 Million INR | 19.91% |
2022 | -205.36 Million INR | -28.98% |
2021 | -159.22 Million INR | -18.47% |
2020 | -134.39 Million INR | -2.31% |
2019 | -131.36 Million INR | -250.14% |
2018 | -37.51 Million INR | 58.07% |
2017 | -89.47 Million INR | 14.23% |
2016 | -104.31 Million INR | -1.0% |
2015 | -103.29 Million INR | 13.52% |
2014 | -119.43 Million INR | -75.32% |
2013 | -68.12 Million INR | -67.56% |
2012 | -40.65 Million INR | -28734.75% |
2011 | -141 Thousand INR | -100.18% |
2010 | 80.28 Million INR | -33.05% |
2009 | 119.92 Million INR | -2.39% |
2008 | 122.85 Million INR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | - INR | 100.0% |
2023 Q4 | -164.47 Million INR | -162.85% |
2023 Q3 | 261.69 Million INR | 230.29% |
2023 Q2 | -200.85 Million INR | -177.37% |
2023 Q1 | 259.61 Million INR | 226.42% |
2023 FY | -164.47 Million INR | 19.91% |
2022 Q3 | 166.85 Million INR | 203.23% |
2022 Q2 | -161.63 Million INR | -185.91% |
2022 FY | -205.36 Million INR | -28.98% |
2022 Q1 | 188.15 Million INR | 218.17% |
2022 Q4 | -205.36 Million INR | -223.08% |
2021 Q4 | -159.22 Million INR | -173.96% |
2021 Q3 | 215.28 Million INR | 240.73% |
2021 Q1 | 226.23 Million INR | 268.33% |
2021 FY | -159.22 Million INR | -18.47% |
2021 Q2 | -152.97 Million INR | -167.62% |
2020 FY | -134.39 Million INR | -2.31% |
2020 Q1 | 229.88 Million INR | 275.0% |
2020 Q2 | -178.48 Million INR | -177.64% |
2020 Q4 | -134.39 Million INR | -155.11% |
2020 Q3 | 243.86 Million INR | 236.63% |
2019 FY | -131.36 Million INR | -250.14% |
2019 Q1 | 172.65 Million INR | 560.2% |
2019 Q3 | 147.15 Million INR | 266.19% |
2019 Q4 | -131.36 Million INR | -189.27% |
2019 Q2 | -88.54 Million INR | -151.28% |
2018 Q2 | -71.97 Million INR | -142.57% |
2018 Q4 | -37.51 Million INR | -122.11% |
2018 FY | -37.51 Million INR | 58.07% |
2018 Q3 | 169.7 Million INR | 335.79% |
2018 Q1 | 169.08 Million INR | 288.97% |
2017 Q2 | -92.97 Million INR | -148.44% |
2017 FY | -89.47 Million INR | 14.23% |
2017 Q4 | -89.47 Million INR | -155.13% |
2017 Q3 | 162.29 Million INR | 274.55% |
2017 Q1 | 191.93 Million INR | 278.27% |
2016 Q2 | -149.43 Million INR | -174.62% |
2016 Q1 | 200.26 Million INR | 293.89% |
2016 FY | -104.31 Million INR | -1.0% |
2016 Q4 | -107.66 Million INR | -155.66% |
2016 Q3 | 193.43 Million INR | 229.45% |
2015 Q2 | -199.59 Million INR | -195.2% |
2015 Q1 | 209.66 Million INR | 275.55% |
2015 FY | -103.29 Million INR | 13.52% |
2015 Q4 | -103.29 Million INR | -135.87% |
2015 Q3 | 287.95 Million INR | 244.27% |
2014 Q4 | -119.43 Million INR | -166.85% |
2014 Q2 | -94.76 Million INR | 0.0% |
2014 FY | -119.43 Million INR | -75.32% |
2014 Q3 | 178.66 Million INR | 288.53% |
2013 Q1 | 118.63 Million INR | 391.8% |
2013 Q3 | 157.59 Million INR | 277.51% |
2013 Q4 | -68.12 Million INR | -143.23% |
2013 Q2 | -88.77 Million INR | -174.83% |
2013 FY | -68.12 Million INR | -67.56% |
2012 Q4 | -40.65 Million INR | 0.0% |
2012 FY | -40.65 Million INR | -28734.75% |
2011 FY | -141 Thousand INR | -100.18% |
2011 Q4 | -141 Thousand INR | 0.0% |
2010 FY | 80.28 Million INR | -33.05% |
2009 FY | 119.92 Million INR | -2.39% |
2008 FY | 122.85 Million INR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
ANG Lifesciences India Limited | 671.01 Million INR | 124.511% |
Add-Shop E-Retail Limited | 116.24 Million INR | 241.482% |
Bacil Pharma Limited | 569 Thousand INR | 29005.097% |
Beryl Drugs Limited | 48.7 Million INR | 437.665% |
Cian Healthcare Limited | 544.97 Million INR | 130.18% |
Colinz Laboratories Limited | -64.3 Million INR | -155.773% |
Concord Drugs Limited | 164.48 Million INR | 199.99% |
Deccan Health Care Limited | -7.07 Million INR | -2224.336% |
Gennex Laboratories Limited | -552.54 Million INR | 70.234% |
Gujarat Terce Laboratories Limited | 37.76 Million INR | 535.521% |
Ishita Drugs and Industries Limited | -48.09 Million INR | -241.948% |
Kerala Ayurveda Limited | 447.82 Million INR | 136.726% |
Kwality Pharmaceuticals Limited | 921.75 Million INR | 117.843% |
Mercury Laboratories Limited | -26.72 Million INR | -515.324% |
Panchsheel Organics Limited | -157.82 Million INR | -4.213% |
Parmax Pharma Limited | 51.8 Million INR | 417.449% |
Parnax Lab Limited | 787.61 Million INR | 120.882% |
Patidar Buildcon Limited | 25.12 Million INR | 754.581% |
Pharmaids Pharmaceuticals Limited | 37.28 Million INR | 541.08% |
Phaarmasia Limited | -4.89 Million INR | -3258.587% |
Sandu Pharmaceuticals Limited | -11.43 Million INR | -1338.933% |
Sastasundar Ventures Limited | -297.24 Million INR | 44.669% |
SHELTER PHARMA LIMITED | -44.62 Million INR | -268.568% |
Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | -180.733% |
SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 115.71% |
Sunil Healthcare Limited | 625.4 Million INR | 126.298% |
Syschem (India) Limited | 3.53 Million INR | 4756.569% |
Trident Lifeline Limited | 117.56 Million INR | 239.903% |
Transchem Limited | -3.16 Million INR | -5099.81% |
Tyche Industries Limited | -788.94 Million INR | 79.153% |
Vikram Thermo (India) Limited | 38.62 Million INR | 525.812% |
Vasundhara Rasayans Limited | -76.15 Million INR | -115.973% |
Zenith Healthcare Limited | -25.45 Million INR | -546.07% |
Zenotech Laboratories Limited | -196.85 Million INR | 16.452% |
Hindustan Bio Sciences Limited | 25.21 Million INR | 752.313% |
KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 138.096% |
Chemo Pharma Laboratories Limited | -6.05 Million INR | -2614.922% |
MedPlus Health Services Limited | 8.67 Billion INR | 101.895% |
Sanjivani Paranteral Limited. | -85.95 Million INR | -91.355% |
Smruthi Organics Limited | 111.28 Million INR | 247.786% |
Trimurthi Limited | -1.17 Million INR | -13859.43% |
Zenlabs Ethica Limited | 139.54 Million INR | 217.861% |
Makers Laboratories Limited | 172.59 Million INR | 195.295% |
Lactose (India) Limited | 373.97 Million INR | 143.979% |
Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 123.857% |
Roopa Industries Limited | 216.01 Million INR | 176.138% |
PANJON LTD. | -12.8 Million INR | -1184.119% |
TIAAN CONSUMER LIMITED | 13.44 Million INR | 1323.28% |
Anuh Pharma Limited | -69.8 Million INR | -135.607% |
Crestchem Limited | -1.45 Million INR | -11242.759% |
Emmessar Biotech & Nutrition Limited | -60.73 Million INR | -170.813% |
PRAVEG LIMITED | -434.98 Million INR | 62.19% |
Fredun Pharmaceuticals Limited | 1.04 Billion INR | 115.754% |
Shukra Pharmaceuticals Limited | -68.26 Million INR | -140.929% |
Norris Medicines Limited | 214.86 Million INR | 176.547% |
Denis Chem Lab Limited | -236.28 Million INR | 30.393% |
Veerhealth Care Limited | -2.38 Million INR | -6796.017% |
Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 79.231% |
OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 128.787% |
Godavari Drugs Limited | 530.02 Million INR | 131.031% |
SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | -1666.595% |
Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 224.504% |
Vivanza Biosciences Limited | 50.02 Million INR | 428.769% |
Medi-Caps Limited | -3.21 Million INR | -5017.299% |
DECIPHER LABS LIMITED | -93.13 Million INR | -76.587% |
Shree Ganesh Remedies Limited | 201.85 Million INR | 181.478% |
Gujarat Themis Biosyn Limited | -53.88 Million INR | -205.23% |
Bharat Parenterals Limited | 1.48 Billion INR | 111.048% |
Vista Pharmaceuticals Limited | 78.7 Million INR | 308.973% |
Coral Laboratories Limited | -612.82 Million INR | 73.162% |
Evoq Remedies Limited | 41.14 Million INR | 499.704% |
Trinity League India Limited | -12 Thousand INR | -1370483.333% |
KOBO BIOTECH LIMITED | 1.39 Billion INR | 111.789% |
Natural Capsules Limited | 956.68 Million INR | 117.192% |
Auro Laboratories Limited | 252.51 Million INR | 165.133% |